Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update.
作者信息
Tung Nadine M, Zakalik Dana, Somerfield Mark R
机构信息
Beth Israel Deaconess Medical Center, Boston, MA.
Beaumont Health, Royal Oak, MI.
出版信息
J Clin Oncol. 2021 Sep 10;39(26):2959-2961. doi: 10.1200/JCO.21.01532. Epub 2021 Aug 3.
PMID:34343058
Abstract
摘要
Zotero 插件